Abstract
Background
The development of cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors for management of neurodegenerative diseases such as Alzheimer’s disease (AD) has come with their undesirable side effects. Hence, research for potent but natural ChE and MAO inhibitors with little or no side effects is essential. This study investigated the potentials of alkaloid extracts from two Cola species as nutraceuticals for prevention and management of AD.
Methods
Alkaloid extracts were obtained from two Cola species (Cola nitida [KN] and Cola acuminata [KA]) by solvent extraction method. The extracts were characterized for their alkaloid contents using gas chromatography (GC). The effects of the extracts on ChE and MAO activities were investigated in vitro. Also, the extracts’ ability to inhibit Fe2+-induced lipid peroxidation in rat brain homogenate, scavenge DPPH and OH radicals, as well as chelate Fe2+ were determined.
Results
GC characterization revealed the presence of augustamine and undulatine as the predominant alkaloids in the extracts. There was no significant (P > 0.05) difference in the inhibitory effects of the extracts on ChE activities. However, KA extract exhibited significantly higher (P < 0.05) MAO inhibitory effect than KN. Also, KA extract inhibited Fe2+- induced malondialdehyde (MDA) production in rat brain homogenate more significantly than KN, while there was no significant difference in DPPH and OH radicals scavenging, as well as Fe2+-chelating abilities of the extracts.
Conclusions
Our findings revealed that KN and KA alkaloid extracts exhibited significant effect in vitro on biological pathways that may contribute to neuroprotection for the management of neurodegenerative diseases.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
[1] Pepeu G, Grossi C, Fiorella C. The brain cholinergic system in neurodegenerative diseases. Anl Res Revi Biol. 2015;6:1–19.10.9734/ARRB/2015/14623Search in Google Scholar
[2] Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in alzheimer disease. Cold Spring Harb Perspect Med. 2011;1(1):a006189.10.1101/cshperspect.a006189Search in Google Scholar
[3] Ademiluyi AO, Ogunsuyi OB, Oboh G. Alkaloid extracts from jimson weed (datura stramonium L.) modulate purinergic enzymes in rat brain. Neurotoxicol. 2016;56:107–17.10.1016/j.neuro.2016.06.012Search in Google Scholar
[4] Ltm M. Bohnen NI cholinergic dysfunction in parkinson’s disease. Curr Neurol Neurosci Report. 2013;13:377.10.1007/s11910-013-0377-9Search in Google Scholar
[5] Mufson EJ, Counts SE, Perez S, Ginsberg SD. Cholinergic system during the progression of alzheimer’s disease: therapeutic implications. Expert Rev Neurotherapeu. 2008;8:1703–18.10.1586/14737175.8.11.1703Search in Google Scholar
[6] Melo JB, Agostinho P, Oliveira CR. Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res. 2003;45:117–27.10.1016/S0168-0102(02)00201-8Search in Google Scholar
[7] Tapia-González S, Giráldez-Pérez RM, Cuartero MI, Casarejos MJ, Má M, Wang XF, et al. Dopamine and α-synuclein dysfunction in smad3 null mice. Mol Neurodegen. 2011;6:1–23.10.1186/1750-1326-6-72Search in Google Scholar PubMed PubMed Central
[8] Stansley JB, Yamamoto KB. L-Dopa and brain serotonin system dysfunction. Toxics. 2015;3:75–88.10.3390/toxics3010075Search in Google Scholar PubMed PubMed Central
[9] Uttara B, Ajay VS, Paolo Z, Mahajan RT. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7:65–74.10.2174/157015909787602823Search in Google Scholar PubMed PubMed Central
[10] Li L, Hu GK. Pink1 protects cortical neurons from thapsigargin-induced oxidative stress and neuronal apoptosis. Biosci Rep. 2015;35:1–8.10.1042/BSR20140104Search in Google Scholar PubMed PubMed Central
[11] Tavares L, Fortalezas S, Tyagi M, Barata D, Serra AT, Martins Duarte CM, et al. Bioactive compounds from endemic plants of Southwest Portugal: inhibition of acetylcholinesterase and radical scavenging activities. Pharma Biol. 2012;50:239–46.10.3109/13880209.2011.596209Search in Google Scholar
[12] Ademosun OA, Oboh G. Comparison of the inhibition of monoamine oxidase and butyrylcholinesterase activities by infusions from green tea and some citrus peels. Int J Alzheimer’s Dis. 2014;2014:1–5.10.1155/2014/586407Search in Google Scholar
[13] Nwanna EE, Oyeleye SI, Ogunsuyi OB, Oboh G, Boligon AA, Athayde ML. In vitro neuroprotective properties of some commonly consumed green leafy vegetables in Southern Nigeria. NFS J. 2016;2:19–24.10.1016/j.nfs.2015.12.002Search in Google Scholar
[14] Meyers RA. Encyclopedia of Physical Science and Technology Alkaloids, 3rd ed. Cambridge, Massachusetts: Academic Press, 2002.Search in Google Scholar
[15] Ng YP, Or TCT, Ip NY. Plant alkaloids as drug leads for Alzheimer’s disease. Neurochem Int. 2015;89:260–70.10.1016/j.neuint.2015.07.018Search in Google Scholar
[16] Mehta M, Abdu A, Marwan S. New acetylcholinesterase inhibitors for alzheimer’s disease. Int J Alzheimer’s Dis. 2012;2012:1–8.10.1155/2012/728983Search in Google Scholar
[17] Odebunmi EO, Oluwaniyi OO, Awolola GV, Adediji OD. Proximate and nutritional composition of kola nut (Cola nitida), bitter cola (garcinia cola) and alligator pepper (afromomum melegueta). Afr J Biotechnol. 2009;8:308–10.Search in Google Scholar
[18] Jaiyeola CO. Preliminary studies on the use of kolanuts (Cola nitida) for soft drink production. J Food Technol Africa. 2001;6:25–6.10.4314/jfta.v6i1.19280Search in Google Scholar
[19] Leaky RR. Potential for novel food production from agroforestry trees: A review. Food chemistry. 1999;66:1-14.10.1016/S0308-8146(98)00072-7Search in Google Scholar
[20] Harborne JB. Phytochemical methods: a guide to modern techniques of plant analysis, 3rd ed. London: Chapman and Hall, 1998: 302.Search in Google Scholar
[21] Ademiluyi AO, Ogunsuyi OB, Oboh G, Agbebi OJ. Jimson weed (Datura stramonium L.) alkaloid extracts modulate cholinesterase and monoamine oxidase activities in vitro: possible modulatory effect on neuronal function. Comp Clin Pathol. 2016;25:733–41.10.1007/s00580-016-2257-6Search in Google Scholar
[22] Ngounou FN, Manfouo RN, Tapondjou LA, Lontsi D, Kuete V, Penlap V, et al. Antimicrobial diterpenoid alkaloids from erythrophleum suaveolens (guill. & perr.) brenan. Bull Chem Soc Ethiop. 2005;19:221–6.10.4314/bcse.v19i2.21127Search in Google Scholar
[23] Singleton VL, Orthofor R, Lamuela-Raventos RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocaltau reagent. Methods Enzymol. 1999;299:152–78.10.1016/S0076-6879(99)99017-1Search in Google Scholar
[24] Brunner JH. Direct spectrophometer dertermination of saponin. Anim Chem. 1984;34:1314–26.Search in Google Scholar
[25] Perry NS, Houghton PJ, Sampson J, Theobald AE, Hart S, Lis‐Balchin M, et al. In‐vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer’s disease. J Pharm Pharmacol. 2001;53:1347–56.10.1211/0022357011777846Search in Google Scholar
[26] Turski W, Turska E, Bellard MG. Modification of the spectrophotometric method of the determination of monoamine oxidase. Enzyme. 1973;14:211–20.10.1159/000459482Search in Google Scholar
[27] Nav B, Dalmolin GD, Fonini G, Rubin MA, Rocha JBT. Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res. 2004;1008:245–51.10.1016/j.brainres.2004.02.036Search in Google Scholar
[28] Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–8.10.1016/0003-2697(79)90738-3Search in Google Scholar
[29] Gyamfi MA, Yonamine M, Aniya Y. Free-radical scavenging action of medicinal herbs from Ghana: thonningia sanguinea on experimentally induced liver injuries. Gen Pharmacol. 1999;32:661–7.10.1016/S0306-3623(98)00238-9Search in Google Scholar
[30] Halliwell B, Gutteridge JMC. Formation of a thiobarbituric-acid reactive substance from deoxyribose in the presence of iron salts. FEBS Lett. 1981;128:347–52.10.1016/0014-5793(81)80114-7Search in Google Scholar
[31] Minotti G, Aust SD. An investigation into the mechanism of citrate-Fe2＋-dependent lipid peroxidation. Free Rad Biol Med. 1987;3:379–87.10.1016/0891-5849(87)90016-5Search in Google Scholar
[32] Dewole EA, Dewumi DF, Alabi JY, Adegoke A. Proximate and phytochemical of cola nitida and cola acuminata. Pak J Biol Sci. 2013;16:1593–6.10.3923/pjbs.2013.1593.1596Search in Google Scholar PubMed
[33] Konrath EL, Neves BM, Lunardi PS. dos Santos Passos C, Simões-Pires A, Ortega MG, et al. Investigation of the in vitro and ex vivo acetylcholinesterase and antioxidant activities of traditionally used lycopodium species from South America on alkaloid extracts. J Ethnopharmacol. 2012;139:58–67.10.1016/j.jep.2011.10.042Search in Google Scholar PubMed
[34] Papandreou MA, Dimakopoulou A, Linardaki ZI, Cordopatis P, Klimis-Zacas D, Margarity M, et al. Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behav Brain Res. 2009;198:352–8.10.1016/j.bbr.2008.11.013Search in Google Scholar PubMed
[35] López S, Bastida J, Viladomat F, Codina C. Acetylcholinesterase inhibitory activity of some amaryllidaceae alkaloids and narcissus extracts. Life Sci. 2002;71:2521–9.10.1016/S0024-3205(02)02034-9Search in Google Scholar
[36] Ortega MG, Agnese AM, Cabrera JL. Anticholinesterase activity in an alkaloid extract of huperzia saururus. Phytomed. 2004;11:539–43.10.1016/j.phymed.2003.07.006Search in Google Scholar PubMed
[37] Nwanna EE, Adebayo AA, Oboh G, Ogunsuyi OB, Ademosun AO. Modulatory effects of alkaloid extract from gongronema latifolium (utazi) and lasianthera africana (editan) on activities of enzymes relevant to neurodegeneration. J Diet Suppl. 2018;1–13.10.1080/19390211.2018.1426075Search in Google Scholar PubMed
[38] Yoon NY, Chung HY, Kim HR, Choi JS. Acetyl‐and butyrylcholinesterase inhibitory activities of sterols and phlorotannins from Ecklonia stolonifera. Fish Sci. 2008;74:200–7.10.1111/j.1444-2906.2007.01511.xSearch in Google Scholar
[39] Kozurkova M, Hamulakova S, Gazova Z, Paulikova H, Kristian P. Neuroactive multifunctional tacrine congeners with cholinesterase, anti-amyloid aggregation and neuroprotective properties. Pharmaceut. 2011;4:382–418.10.3390/ph4020382Search in Google Scholar
[40] Xu LF, Chu WJ, Qing XY, Li S, Wang XS, Qing GW, et al. Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models. Neuropharmacol. 2006;50:934–40.10.1016/j.neuropharm.2006.01.003Search in Google Scholar PubMed
[41] Ademosun AO, Oboh G. Inhibition of acetylcholinesterase activity and Fe2+-induced lipid peroxidation in rat brain in vitro by some citrus fruit juices. J Med Food. 2012;15:428–34.10.1089/jmf.2011.0226Search in Google Scholar PubMed
[42] Cahlíková L, Valterová I, Macáková K, Opletal L. Analysis of amaryllidaceae alkaloids from zephyranthes grandiflora by GC/MS and their cholinesterase activity. Revista Brasileira De Farmacognosia. 2011;21:575–80.10.1590/S0102-695X2011005000089Search in Google Scholar
[43] Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scali C, et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102: 17213–8.10.1073/pnas.0508575102Search in Google Scholar PubMed PubMed Central
[44] Van Rijn RM, Rhee IK, Verpoorte R. Isolation of acetylcholinesterase inhibitory alkaloids from nerine bowdenii. Nat Prod Res. 2010;24:222–5.10.1080/14786410802263758Search in Google Scholar PubMed
[45] Roseiroa LB, Amelia PR, Maria MS Polyphenols as acetylcholinesterase inhibitors: structural specificity and impact on human disease. Nutri Aging. 2012;1:99–111.10.3233/NUA-2012-0006Search in Google Scholar
[46] Khalid A, Azim MK, Parveen S, Choudhary MI. Structural basis of acetylcholinesterase inhibition by triterpenoidal alkaloids. Biochem Biophysic Res Commun. 2005;331:1528–32.10.1016/j.bbrc.2005.03.248Search in Google Scholar PubMed
[47] Pisani L, Catto M, Leonetti F, Nicolotti O, Stefanachi A, Campagna F, et al. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases. Curr Med Chem. 2011;18:4568–87.10.2174/092986711797379302Search in Google Scholar PubMed
[48] Dias V, Junn E, Mouradian MM. The role of oxidative stress in parkinson’s disease. J Parkinsons Dis. 2013;3:461–91.10.3233/JPD-130230Search in Google Scholar PubMed PubMed Central
[49] Nagatsu T, Sawada M. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to parkinson’s disease: possible implications of glial cells. In Oxidative Stress Neuroprot. 2006;71:53–65.10.1007/978-3-211-33328-0_7Search in Google Scholar PubMed
[50] Sulzer D, Zecca L. Intraneuronal dopamine-quinone synthesis: A review. Neurotoxic Res. 1999;1:181–95.10.1007/BF03033289Search in Google Scholar PubMed
[51] Passos CDS, Simoes-pires C, Henriques A, Cuendet M, Carrupt PA, Christen P. Alkaloids as inhibitors of monoamine oxidases and their role in the central nervous system. Stud Nat Prod Chem. 2014;43:123–43.10.1016/B978-0-444-63430-6.00004-7Search in Google Scholar
[52] Zhi K, Yang Z, Sheng J, Shu Z, Shi Y, Peroxidase-linked spectrophotometric A. Assay for the detection of monoamine oxidase inhibitors. Iranian J Pharmaceu Res. 2016;15:131–9.Search in Google Scholar
[53] Oboh G, Nwanna EE, Oyeleye SI, Olasehinde TA, Ogunsuyi OB, Boligon AA. In vitro neuroprotective potentials of aqueous and methanol extracts from Heinsia crinita leaves. Food Sci Human Well. 2016;5:95–102.10.1016/j.fshw.2016.03.001Search in Google Scholar
[54] Marksberry WR, Lovell MA. Damage to lipids, proteins, DNA and RNA in mild cognitive impairment. Arch Neurol. 2007;64:954–56.10.1001/archneur.64.7.954Search in Google Scholar PubMed
[55] Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.10.1016/j.biocel.2006.07.001Search in Google Scholar PubMed
[56] Cherubini AC, Ruggiero MC, Polidori PM. Potential markers of oxidative stress in stroke. Free Radic Biol Med. 2005;39:841–52.10.1016/j.freeradbiomed.2005.06.025Search in Google Scholar PubMed
[57] Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, et al. Oxidative stress, prooxidants, and antioxidants: the interplay. BioMed Res Int. 2014;2014:1–19.10.1155/2014/761264Search in Google Scholar PubMed PubMed Central
[58] Shirwaikar A, Shirwaikar A, Rajendran K, Punitha ISR. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol Pharma Bull. 2006;29:1906–10.10.1248/bpb.29.1906Search in Google Scholar PubMed
[59] Facecchia K, Fochesato LA, Ray SD, Stohs SJ, Pandey S. Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies. J Toxicol. 2011;2011:1–12.10.1155/2011/683728Search in Google Scholar PubMed PubMed Central
[60] Salganik R. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J America College Nutri. 2011;20:464–720.10.1080/07315724.2001.10719185Search in Google Scholar PubMed
© 2019 Walter de Gruyter GmbH, Berlin/Boston
